Literature DB >> 32256220

A comparison of a moderately hypofractionated IMRT planning technique used in a randomised UK external beam radiotherapy trial with an in-house technique for localised prostate cancer.

Ian Gleeson1.   

Abstract

AIM: To compare the radiotherapy technique used in a randomised trial with VMAT and an in-house technique for prostate cancer.
BACKGROUND: Techniques are evolving with volumetric modulated arc therapy (VMAT) commonly used. The CHHiP trial used a 3 PTV forward planned IMRT technique (FP_CH). Our centre has adopted a simpler two PTV technique with locally calculated margins.
MATERIALS AND METHODS: 25 patients treated with FP_CH to 60 Gy in 20 fractions were re-planned with VMAT (VMAT_CH) and a two PTV protocol (VMAT_60/52 and VMAT_60/48). Target coverage, conformity index (CI), homogeneity index (HI), monitor units (MU) and dose to the rectum, bladder, hips and penile bulb were compared.
RESULTS: PTV coverage was high for all techniques. VMAT_CH plans had better CI than FP_CH (p ≤  0.05). VMAT_60/52/48 plans had better CI than VMAT_CH. FP_CH had better HI and fewer MU than VMAT (p ≤  0.05). More favourable rectum doses were found for VMAT _CH than FP_CH (V48.6, V52.8, V57, p ≤  0.05) with less difference for bladder (p ≥  0.05). Comparing VMAT_CH to VMAT_60/52/48 showed little differences for the bladder and rectum but VMAT_CH had larger penile bulb doses (V40.8, V48.6, mean, D2, p ≤  0.05). Femoral head doses (V40.8) were similarly low for all techniques (p = ≥ 0.05).
CONCLUSION: VMAT produced more conformal plans with smaller rectum doses compared to FP_CH albeit worse HI and more MU. VMAT_60/52 and VMAT_60/48 plans had similar rectal and bladder doses to VMAT_CH but better CI and penile bulb doses which may reduce toxicity. Crown
Copyright © 2020 Published by Elsevier B.V. on behalf of Greater Poland Cancer Centre. All rights reserved.

Entities:  

Keywords:  Dosimetric comparison; Hypofractionation; Intensity modulated radiotherapy; Planning technique; Prostate cancer

Year:  2020        PMID: 32256220      PMCID: PMC7118276          DOI: 10.1016/j.rpor.2020.03.010

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  22 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Comparison of three dimensional conformal radiation therapy, intensity modulated radiation therapy and volumetric modulated arc therapy for low radiation exposure of normal tissue in patients with prostate cancer.

Authors:  Aydin Cakir; Zuleyha Akgun; Merdan Fayda; Fulya Agaoglu
Journal:  Asian Pac J Cancer Prev       Date:  2015

3.  Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?

Authors:  Larry Kestin; Neal Goldstein; Frank Vicini; Di Yan; Howard Korman; Alvaro Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-11-01       Impact factor: 7.038

4.  A VMAT planning solution for prostate patients using a commercial treatment planning system.

Authors:  C J Boylan; C Golby; C G Rowbottom
Journal:  Phys Med Biol       Date:  2010-07-05       Impact factor: 3.609

5.  Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.

Authors:  William C Jackson; Jessica Silva; Holly E Hartman; Robert T Dess; Amar U Kishan; Whitney H Beeler; Laila A Gharzai; Elizabeth M Jaworski; Rohit Mehra; Jason W D Hearn; Todd M Morgan; Simpa S Salami; Matthew R Cooperberg; Brandon A Mahal; Payal D Soni; Samuel Kaffenberger; Paul L Nguyen; Neil Desai; Felix Y Feng; Zachary S Zumsteg; Daniel E Spratt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-06       Impact factor: 7.038

6.  Forward- and Inverse-Planned Intensity-Modulated Radiotherapy in the CHHiP Trial: A Comparison of Dosimetry and Normal Tissue Toxicity.

Authors:  O F Naismith; C Griffin; I Syndikus; C South; H Mayles; P Mayles; V Khoo; C Scrase; J Graham; S Hassan; E Hall; D P Dearnaley
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-06-06       Impact factor: 4.126

7.  A Retrospective Planning Analysis Comparing Volumetric-Modulated Arc Therapy (VMAT) to Intensity-Modulated Radiation Therapy (IMRT) for Radiotherapy Treatment of Prostate Cancer.

Authors:  Craig A Elith; Fred Cao; Shane E Dempsey; Naomi Findlay; Helen Warren-Forward
Journal:  J Med Imaging Radiat Sci       Date:  2012-08-03

8.  Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: results from a randomized trial.

Authors:  Wilma D Heemsbergen; Abrahim Al-Mamgani; Marnix G Witte; Marcel van Herk; Joos V Lebesque
Journal:  Radiother Oncol       Date:  2013-05-03       Impact factor: 6.280

9.  Intra-fraction motion of the prostate during treatment with helical tomotherapy.

Authors:  Simon J Thomas; Mark Ashburner; George Samuel J Tudor; Jo Treeby; June Dean; Donna Routsis; Yvonne L Rimmer; Simon G Russell; Neil G Burnet
Journal:  Radiother Oncol       Date:  2013-10-12       Impact factor: 6.280

10.  Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.

Authors:  Douglas H Brand; Alison C Tree; Peter Ostler; Hans van der Voet; Andrew Loblaw; William Chu; Daniel Ford; Shaun Tolan; Suneil Jain; Alexander Martin; John Staffurth; Philip Camilleri; Kiran Kancherla; John Frew; Andrew Chan; Ian S Dayes; Daniel Henderson; Stephanie Brown; Clare Cruickshank; Stephanie Burnett; Aileen Duffton; Clare Griffin; Victoria Hinder; Kirsty Morrison; Olivia Naismith; Emma Hall; Nicholas van As
Journal:  Lancet Oncol       Date:  2019-09-17       Impact factor: 41.316

View more
  3 in total

1.  Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer?

Authors:  Dorota Maria Borowicz; Agnieszka Skrobała; Marta Kruszyna-Mochalska; Julian Malicki
Journal:  Radiol Oncol       Date:  2022-03-28       Impact factor: 4.214

2.  Translation and Expression of Professional Terms of Public Emergencies in External Reports.

Authors:  Zhanwei Zhu; Chenhui Wang
Journal:  J Environ Public Health       Date:  2022-09-30

3.  Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy.

Authors:  Dorota Maria Borowicz; Konstantin N Shipulin; Gennady V Mytsin; Agnieszka Skrobała; Piotr Milecki; Victor N Gayevsky; Vladimir Vondráček; Julian Malicki
Journal:  J Pers Med       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.